SCHEMBL7144538

SCHEMBL7144538

COc1ccc(-c2ccc(C)cc2)n2nc(N)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 9/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PDE10A Q9Y233 1/20 0.48
JAK1 P23458 1/20 0.47
HTT P42858 1/20 0.45
HSP90AB1 P08238 2/20 0.43
NTRK1 P04629 1/20 0.41
PIM1 P11309 1/20 0.41
MAPT P10636 3/20 0.40
HSD17B10 Q99714 1/20 0.40
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40
TUBA4A P68366 1/20 0.40
TUBB4B P68371 1/20 0.40
TUBB3 Q13509 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7043078 0.89 JAK1 (0.60) PDE4DKDM4EALDH1A1HPGDPDE10A
SCHEMBL2257907 0.87 MAPT (0.49) PDE4DKDM4EALDH1A1HPGDPDE10A
SCHEMBL7146898 0.87 KDM4E (0.51) PDE4DKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL2250839 0.87 PDE4D (0.64) PDE4DKDM4EPDE10AJAK1HSP90AB1
SCHEMBL7143153 0.85 PDE4D (0.46) PDE4DKDM4EALDH1A1HPGDPDE10A
SCHEMBL7145674 0.84 PDE10A (0.50) PDE4DHPGDPDE10AJAK1HSP90AB1
SCHEMBL6875680 0.80 PDE10A (0.44) PDE4DPDE10AJAK1HSP90AB1TUBB4A
SCHEMBL7043841 0.79 MAPT (0.51) PDE4DKDM4EALDH1A1HPGDPDE10A
SCHEMBL7143142 0.78 JAK2 (0.48) PDE4DPDE10AHSP90AB1MAPT
SCHEMBL7146570 0.78 PDE4D (0.48) PDE4DSMN1; SMN2PDE10AJAK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed